Paragon Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,980
Closed -$1.66M 76
2024
Q1
$1.66M Buy
+4,980
New +$1.52M 0.67% 52
2023
Q4
Sell
-3,798
Closed -$934K 114
2023
Q3
$934K Buy
3,798
+1,132
+42% +$310K 0.39% 64
2023
Q2
$809K Buy
+2,666
New +$741K 0.26% 75
2022
Q3
Sell
-7,391
Closed -$1.24M 63
2022
Q2
$1.24M Sell
7,391
-1,587
-18% -$341K 0.62% 48
2022
Q1
$2.25M Buy
+8,978
New +$2.25M 0.94% 28

Other funds holding HCA

Paragon Advisors's HCA Position: Q2 2024 in Review

Paragon Advisors sold out of HCA Healthcare (HCA) in Q2 2024, closing a stake of 4,980 shares — an estimated $1.66M sold.

Paragon Advisors first reported a position in HCA in Q1 2022 and held it in 5 quarters. The position peaked at $2.25M in Q1 2022. 1,155 funds tracked by Wall St. Rank hold HCA as of Q2 2024.

  • Paragon Advisors reported no remaining HCA Healthcare position as of Q2 2024 after selling out during the quarter.
  • Paragon Advisors sold 4,980 HCA Healthcare shares in Q2 2024, an estimated $1.66M.
  • Paragon Advisors first reported a position in HCA Healthcare in Q1 2022 and held it in 5 quarters.
  • Paragon Advisors's HCA Healthcare position peaked at $2.25M in Q1 2022.
  • 1,155 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2024.

Based on Paragon Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.